Skip to main content

International Psoriasis Council

International Psoriasis Council
subscribe
6   What's New
Search
subscribe
Search

Advancing Knowledge. Improving Care.

Alan

Menter

,

MD

Chief, Division of Dermatology Baylor University Medical Center, Dallas TX

Clinical Professor of Dermatology University of Texas, Southwestern Medical School

Director, Fellowship Program Baylor Psoriasis Center, Dallas TX

Chair, Psoriasis Guidelines Committee, American Academy of Dermatology

Director, Dermatology Residency Program Baylor University Medical Center
Dermatology Associates/Baylor University
Dallas
,
Texas
,
United States
IPC Honorary Founder
Request an Update
Dr. Alan Menter was born in England and is a graduate of the Medical School of the University of Witwatersrand, South Africa. He completed his dermatology residency at Pretoria General Hospital at the University of Pretoria, also in South Africa, and two fellowships in London at Guy’s Hospital and St. John’s Hospital for Diseases of the Skin. In August 2004, Dr. Menter helped found the International Psoriasis Council to raise international awareness of psoriasis as a serious autoimmune disease that can significantly impact the quality of life. Along with Professor Anne Bowcock, they discovered the first gene for Psoriasis, published in the journal Science in 1994. Dr. Menter held the position of clinical director of the National Psoriasis Foundation Gene Bank from 1996 to 2002. He was chairman of the Division of Dermatology at Baylor University Medical Center between 1992 and 2021. He is involved in multiple clinical, investigative, and drug research studies, predominantly those relating to psoriasis. Dr. Menter has published 435+ articles in major dermatology and medical journals, in addition to six books and 21 chapters.
Last Updated:
07/13/2022

Areas of Interest

New drug development, cardiovascular issues in the psoriasis population.

IPC Committees / Groups

Honorary Founding

Languages Spoken

Afrikaans, Dutch, English

Involvement with Other Organization(s)

In close contact with the NPF and a former member of the medical board.
Recent publications

Featured

Blog

2022 World Psoriasis Day.

The IPC is a proud supporter of World Psoriasis Day by uniting for action with IFPA to advance care and change the…

Read More

Blog

World Psoriasis Day.

Biologics and biosimilars have created many new options in psoriasis treatment for patients worldwide, but patients…

Read More

Blog

Commentary: National Psoriasis Foundation COVID-19 Task Force Guidance for Management of Psoriatic Disease.

IPC Founding President Alan Menter and IPC Councilor Ulrich Mrowietz discuss the new guidance on psoriasis care from…

Read More

PDF

Association of Pediatric Psoriasis Severity With Excess and Central Adiposity.

View Report

PDF

Psoriasis, a Proof-of-Principle Condition for Immune-Mediated Inflammatory Disorders: Perspectives Toward Optimal…

View Report

PDF

Long-term Management of Scalp Psoriasis: Perspectives from the International Psoriasis Council.

View Report

Page

Biopharmaceuticals and Biosimilars in Psoriasis: What the Dermatologist Needs to Know.

The entry of biosimilar forms of biopharmaceutical therapies for the treatment of psoriasis and other immune-mediated…

View Report

PDF

Clinical Symptoms of Skin, Nails, and Joints Manifest Independently in Patients with Concomitant Psoriasis and…

View Report

PDF

Improving Clinical Trial Design in Psoriasis: Perspectives from the Global Dermatology Community.

View Report

What's New

Global and Collaborative Research in Psoriasis: IPC Fellows Research Class #1 Recordings

Recordings from the IPC Fellows Research Class #1: Global and Collaborative Research in Psoriasis are now available. Program Chairs Peter van de Kerkhof, MD, PhD, and María Julia Cura, MD, led a faculty of international experts through sessions on unresolved questions in the era of effective psoriasis therapies, building global research collaborations, and connecting psoriasis research across disciplines. Watch to hear from Wolf Henning Boehncke, MD, MA, Christopher Griffiths, OBE, MD, FMedSci, and Georg Stingl, MD, as they share perspectives shaping the next generation of psoriasis research.

WATCH NOW

Wednesday, July 15, 2026

New in the IPC Resource Library: Research Skills

The IPC Resource Library now includes a dedicated Research Skills category, bringing together videos, articles, and presentations focused on building stronger research capabilities in psoriasis. Browse the current collection to find resources on topics from collaborative research methods to career development for researchers at every stage.

WATCH NOW

Thursday, July 13, 2026

New Take Tens on Psoriatic Arthritis

IPC Councilor Anna Lopez Ferrer, MD, PhD, reviews PURE-4, a four-item tool that helps dermatologists screen psoriasis patients for psoriatic arthritis (PsA) risk. She traces its evolution across three studies (2018–2026) into a validated predictor of early PsA.

IPC Councilor André Lucas Ribeiro, MD, reframes PsA as a slow transition from psoriasis, not a sudden event, opening the door to disease interception. He outlines the steps needed to get there, from harmonizing definitions to reducing inflammatory burden.

WATCH NOW

Wednesday, July 8, 2026